Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | hypothetical protein | 0.0284 | 0.2273 | 0.2273 |
Schistosoma mansoni | hypothetical protein | 0.0396 | 0.3932 | 0.2822 |
Loa Loa (eye worm) | hypothetical protein | 0.0396 | 0.3932 | 0.3932 |
Brugia malayi | Plexin repeat family protein | 0.0681 | 0.8151 | 0.8151 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0158 | 0.0396 | 0.5 |
Onchocerca volvulus | 0.0284 | 0.2273 | 0.2299 | |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.0517 | 0.0517 |
Echinococcus granulosus | plexin a4 | 0.0805 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0284 | 0.2273 | 0.2273 |
Loa Loa (eye worm) | hypothetical protein | 0.0284 | 0.2273 | 0.2273 |
Loa Loa (eye worm) | hypothetical protein | 0.0681 | 0.8151 | 0.8151 |
Loa Loa (eye worm) | hypothetical protein | 0.0284 | 0.2273 | 0.2273 |
Schistosoma mansoni | plexin | 0.0396 | 0.3932 | 0.2822 |
Loa Loa (eye worm) | hypothetical protein | 0.0284 | 0.2273 | 0.2273 |
Onchocerca volvulus | 0.0681 | 0.8151 | 1 | |
Loa Loa (eye worm) | sema domain-containing protein | 0.0284 | 0.2273 | 0.2273 |
Entamoeba histolytica | tyrosin kinase, putative | 0.0158 | 0.0396 | 0.5 |
Schistosoma mansoni | plexin | 0.0681 | 0.8151 | 1 |
Brugia malayi | hypothetical protein | 0.0166 | 0.0517 | 0.0517 |
Loa Loa (eye worm) | hypothetical protein | 0.0284 | 0.2273 | 0.2273 |
Brugia malayi | Sema domain containing protein | 0.0284 | 0.2273 | 0.2273 |
Loa Loa (eye worm) | plexin A | 0.0805 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0284 | 0.2273 | 0.2273 |
Loa Loa (eye worm) | hypothetical protein | 0.0284 | 0.2273 | 0.2273 |
Echinococcus multilocularis | plexin a4 | 0.0805 | 1 | 1 |
Brugia malayi | Sema domain containing protein | 0.0284 | 0.2273 | 0.2273 |
Loa Loa (eye worm) | sema domain-containing protein | 0.0284 | 0.2273 | 0.2273 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.